Disclosures for "New Mitigation Protocol for Alemtuzumab Infusion Related Reactions in a Chilean Cohort")
-
Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi.
-
The institution of Dr. Valdes has received research support from Chilean Ministry of Education.
-
Mr. Alba has nothing to disclose.
-
Dr. Capdeville has nothing to disclose.
-
Marianella Hernandez has nothing to disclose.
-
Dr. Rebolledo has nothing to disclose.
-
Ricardo Alonso has nothing to disclose.
-
Felipe Condeza has nothing to disclose.